ConcertAI

ConcertAI es líder en soluciones de IA para oncología, aprovechando los datos del mundo real para acelerar la investigación del cáncer y mejorar los resultados de los pacientes. Su plataforma ofrece análisis avanzados y perspectivas clínicas a empresas farmacéuticas, proveedores de atención sanitaria y organizaciones de investigación. La tecnología de ConcertAI está impulsando la innovación en la oncología de precisión y la atención al paciente.

Gráfico NewsHeat

  • Semana
  • Mes
  • Año
  • Noticias de prensa
  • Noticias corporativas
Haga clic para desbloquear el gráfico

Los datos del gráfico anterior se basan en datos derivados de nuestro modelo de cálculo XP patentado y pueden modificarse, ajustarse y actualizarse sin previo aviso.

Valoración de empresas

  • Valoración
  • Precio de las acciones
  • Financiación acumulada

Los datos de los cuadros y gráficos se basan en datos de fuentes públicas y, aunque hacemos todo lo posible por recopilarlos, es posible que no coincidan con los datos reales del emisor.

Ronda de financiación
Importe de la financiación
Valoración Post-Money
Precio de las acciones
Series C29 mar, 2022
***
***
***
Series B13 ene, 2020
***
***
***
M/A1 dic, 2017
***
***
***
Corporate1 dic, 2011
***
***
***

*** - Para ver los datos, conéctese a su cuenta o cree una nueva.

Noticias relacionadas con ConcertAI53

Filtrar por
Ordenar por
ConcertAI
may 29, 2024 Mostrar en el gráfico

ASCO 2024 study uses ConcertAI Oncology Dataset to find earlier treatment with oliparib monotherapy may improve duration of therapy and overall survival

Leading Cancer Epidemiologist with Long Academic and Industry Career to Lead Regulatory and Registry Practice in Oncology and Hematology CAMBRIDGE, Mass., Jan. 30, 2024 /PRNewswire/ – ConcertAI, the leader in oncology Real-World Data (RWD) and AI SaaS Sol...

ConcertAIhttps://www.concertai.com/news/asco-2024-study-uses-concertai-oncology-dataset-to-find-earlier-treatment-with-oliparib-monotherapy-may-improve-duration-of-therapy-and-overall-survival
ConcertAI
may 29, 2024 Mostrar en el gráfico

ConcertAI: ASCO 2024 study demonstrates that AI-based clinical ...

PRNewswire/ -- ConcertAI, the leader in oncology predictive and generative AI SaaS and Real-World Data (RWD) Solutions for clinical research, announced the....

https://www.prnewswire.com/news-releases/concertai-asco-2024-study-demonstrates-that-ai-based-clinical-trial-screening-is-more-than-3x-faster-than-traditional-methods-302157491.html
ConcertAI
may 29, 2024 Mostrar en el gráfico

ConcertAI: ASCO 2024 study uses ConcertAI Oncology Dataset to ...

PRNewswire/ -- ConcertAI, the leader in oncology predictive and generative AI SaaS and Real-World Data (RWD) Solutions for clinical research, announced the....

https://www.prnewswire.com/news-releases/concertai-asco-2024-study-uses-concertai-oncology-dataset-to-find-earlier-treatment-with-oliparib-monotherapy-may-improve-duration-of-therapy-and-overall-survival-302158150.html
ConcertAI
may 29, 2024 Mostrar en el gráfico

ConcertAI: ASCO 2024 study demonstrates that AI-based clinical trial screening is more than 3x faster than traditional methods

Leading Cancer Epidemiologist with Long Academic and Industry Career to Lead Regulatory and Registry Practice in Oncology and Hematology CAMBRIDGE, Mass., Jan. 30, 2024 /PRNewswire/ – ConcertAI, the leader in oncology Real-World Data (RWD) and AI SaaS Sol...

ConcertAIhttps://www.concertai.com/news/asco-2024-study-demonstrates-that-ai-based-clinical-trial-screening-is-more-than-3x-faster-than-traditional-methods
ConcertAI
may 16, 2024 Mostrar en el gráfico

Dhiraj Carumbaya joins ConcertAI as Senior Vice President and General Manager of TeraRecon

Leading Cancer Epidemiologist with Long Academic and Industry Career to Lead Regulatory and Registry Practice in Oncology and Hematology CAMBRIDGE, Mass., Jan. 30, 2024 /PRNewswire/ – ConcertAI, the leader in oncology Real-World Data (RWD) and AI SaaS Sol...

ConcertAIhttps://www.concertai.com/news/dhiraj-carumbaya-joins-concertai-as-senior-vice-president-and-general-manager-of-terarecon
Ver más (48)

Inversores2

Sixth StreetSixth Street
Declaration PartnersDeclaration Partners

ConcertAI Twitter